Plus Therapeutics Inc (PSTV)
1.360
+0.01
(+0.75%)
USD |
NASDAQ |
Nov 04, 16:00
1.33
-0.03
(-2.21%)
Pre-Market: 20:00
Plus Therapeutics Research and Development Expense (Annual): 9.69M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.69M |
| December 31, 2022 | 9.698M |
| December 31, 2021 | 5.573M |
| December 31, 2020 | 3.481M |
| December 31, 2019 | 5.365M |
| December 31, 2018 | 5.523M |
| December 31, 2017 | 13.36M |
| December 31, 2016 | 16.20M |
| December 31, 2015 | 19.00M |
| December 31, 2014 | 15.10M |
| December 31, 2013 | 17.06M |
| December 31, 2012 | 13.63M |
| December 31, 2011 | 10.90M |
| Date | Value |
|---|---|
| December 31, 2010 | 9.687M |
| December 31, 2009 | 12.23M |
| December 31, 2008 | 17.37M |
| December 31, 2007 | 14.76M |
| December 31, 2006 | 21.98M |
| December 31, 2005 | 15.45M |
| December 31, 2004 | 10.38M |
| December 31, 2003 | 9.071M |
| December 31, 2002 | 7.901M |
| December 31, 2001 | 5.487M |
| December 31, 2000 | 2.584M |
| December 31, 1999 | 1.172M |
| December 31, 1998 | 1.175M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.481M
Minimum
2020
9.698M
Maximum
2022
6.761M
Average
5.573M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |